BioTech Mag Search: Biologic
CAPITAL: A major advance in single-cell RNA data analysis
3 monthes ago - By Phys
New developments in high-throughput biological studies mean that the genes that are active in just a single cell can now be determined. However, analyzing the complex datasets that result can be challenging. Now, a team at Osaka University has developed CAPITAL, a new computational tool for comparing complex datasets from single cells. Their research appears in Nature Communications.
Read more ...Deep learning approach for cancer subtype classification using high-dimensional gene expression data
3 monthes ago - By BMC Bioinformatics
Studies have shown that classifying cancer subtypes can provide valuable information for a range of cancer research, from aetiology and tumour biology to prognosis and personalized treatment. Current methods u...
Read more ...
The headlines of BioTech Mag
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
2nd International Conference on Generic Drugs and Biosimilars
Copying nature to help plants resist viruses
For thousands of years, crops have been shaped by domestication processes. Farmers cross-breed and select new varieties, adapted to constantly changing environments. Although...
A New Phase
The evolution of clinical trials is accelerating, driven by emerging technologies, social imperatives and the next public health crisis.
Biological Dynamics, Perlmutter Cancer Center at NYU Langone Health...
SAN DIEGO & NEW YORK--Biological Dynamics, a company commercializing its exosome-isolation ExoVerita™ platform, announced a collaboration with the Perlmutter Cancer Center at...
Arima Genomics Announces Agreement with Protean BioDiagnostics to Make Arima...
SAN DIEGO--Arima Genomics announces an agreement with Protean BioDiagnostics to make their gene fusion test widely available to clinicians.
Artificial Intelligence Aids Discovery of Super Tight-Binding Antibodies
UC San Diego scientists developed an artificial intelligence tool that could accelerate the development of new high affinity antibody drugs.
Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101
SAN DIEGO-- biotech-Artiva Biotherapeutics Receives FDA Fast Track Designation for AB-101
Biosero and Virscidian Announce Collaboration for Medicinal Chemistry...
SAN DIEGO & CARY, N.C.--Biosero, Inc., developer of laboratory automation solutions to orchestrate scientific discoveries, and Virscidian, developer of solutions to automate...
Poseida Therapeutics Announces Board Change
Eric Ostertag, M.D., Ph.D., Founder and current Executive Chairman, to retire from the Board of Directors and remain a consultant to the Company SAN DIEGO, Jan. 31, 2023...
Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein...
SAN DIEGO-- RNA-Eclipsebio Launches eRibo™ for Improved Methods to Profile Protein Translation; Technology Details Will Be Presented at Keystone Symposia
HiFi long-read sequencing brings more accuracy to population genomics studies
Population genomics initiatives are gaining traction around the world. There are currently more than 20 active programs spread around the globe, and these programs aim to...